Purchase Order 75N95024P00200
Award Date 3/20/24
Potential Completion Date 3/19/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
- This is a $80,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Cambridge Isotope Laboratories, Inc. (doing business as Cambridge Isotope Labs). The contract is for the provision of stable isotopes and isotope-labeled compounds to support ongoing biomedical research programs at NIDA and other National Institutes of Health (NIH) institutes such as the National Institute of Diabetes and Digestive...
- This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to American Radiolabeled Chemicals, Inc., a minority-owned, small disadvantaged business. The $5,692.00 contract is for the delivery of specific quantities of various radioactive chemicals, including carbon-14 labeled ethyl-iodide, to support biomedical research. This purchase order is not associated with a...
- The National Institutes of Health's National Institute on Drug Abuse awarded a $14,900 firm fixed price purchase order to Novandi Chemistry AB of Baltimore, Maryland. The contract calls for the delivery of tritiated heroin to support binding experiments investigating how heroin and its metabolites bind in vivo. As the lead federal agency supporting scientific research on drug abuse and addiction, the National Institute on Drug Abuse uses contracts such as this to further its mission of advancing...
- <p>This is a $12,750.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Hello Bio Inc., a foreign-owned for-profit organization. The contract is to provide 4-hydroxytamoxifen, a compound, in support of NIDA's ongoing intramural research experiments to understand how drug memories are stored in the brain. The contract has an ultimate completion date of October 10, 2025 and does not utilize a set-aside designation.</p>
- This is a firm fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Ipharmasupports LLC, a small business subchapter S corporation based in Denver, Colorado. The contract is for the delivery of F-DOPA synthesis sets, disposable cassette manifolds, tubing, cartridges, reactor reagent kits, precursors, reagents, solvents, and other chemicals necessary to produce an F-18 labeled product. The contract has a ceiling value of $16,779.88 and was awarded on June...
- This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...